BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ACS Cleveland - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.acscleveland.org
X-WR-CALDESC:Events for ACS Cleveland
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220216T193000
DTEND;TZID=America/New_York:20220216T210000
DTSTAMP:20260525T161534
CREATED:20220201T221439Z
LAST-MODIFIED:20220202T182107Z
UID:1145-1645039800-1645045200@www.acscleveland.org
SUMMARY:Feb. 2022 virtual meeting
DESCRIPTION:February 16\, 2022 Virtual Meeting of Cleveland ACS \n\n\n Oliver Glass\, PhD  Category Clinician in Rare Diseases at Pfizer\, Adjunct Assistant Professor of Medicine Duke University \n\n Therapeutic Advances in Rare Diseases: \n\n A Journey into DYRK1A \n\n My passion is to drive advancements in the treatment of rare diseases and bring medicines to patients quicker. DYRK1A syndrome is an autosomal dominant disorder that affects approximately 500 individuals worldwide. Changes in the DYRK1A gene have been linked to intellectual disabilities\, microcephaly\, speech and language impairment\, seizures\, and autism. Learn more about DYRK1A and research opportunities at dyrk1a.org \n\n Dr. Glass received his Bachelor’s in Molecular Genetics from The Ohio State University in 2005\, his PhD in Pathology from Duke University in 2015\, and his MHS in Clinical Research from Duke University in 2020. He served as Director of Research at Duke Health and Well Being and was an Assistant Professor of Medicine. He is currently Category Clinician in Rare Diseases\, Director at Pfizer\, and is an Adjunct Assistant Professor of Medicine at Duke University. No cost to register and participate\n \nRegistration:
URL:https://www.acscleveland.org/event/feb-2022-virtual-meeting/
LOCATION:OH
END:VEVENT
END:VCALENDAR